CDMO News
NJ Bio and Charles River Form Strategic Alliance in ADC Development
NJ Bio and Charles River Laboratories have entered a strategic alliance to enhance and streamline the development and manufacturing of antibody drug conjugates (ADCs) for their clients. The partnership will integrate both companies’ complementary capabilities, covering early development, optimisation, and